Mouse Tumor Model
Mouse Tumor Model - Related Videos
02:43
Tumor Implantation and Injection of a Tumor Vaccine in a Mouse Model
0 Views •
2025
This video demonstrates a cell-based tumor vaccination assay. A mouse, intradermally injected with B16-F10 melanoma cells for tumor formation, is vaccinated with B16-F10 cells secreting Flt3L cytokine near the developed tumor. The secreted Flt3L from the vaccine promotes the maturation and proliferation of dendritic cells that then present tumor antigens to T cells in lymph nodes, triggering a targeted anti-tumor immune response.
01:29
Anti-Tumor Effects of Engineered Pediococcus pentosaceus in a Mouse Tumor Model
0 Views •
2026
Begin with immunodeficient mice bearing subcutaneous xenograft tumors derived from human colorectal cancer cells.Orally administer Pediococcus pentosaceus, a lactic acid bacterium safe for consumption and engineered to secrete an anticancer protein, to the treated mouse.Administer saline to the control mouse.Being acid-tolerant, the bacteria survive the acidic environment of the stomach and reach the intestine.There, they colonize the intestinal lumen and secrete the anticancer protein.The...
05:22
Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model
0 Views •
Cited by 8 •
2015
Circulating tumor cells (CTCs) have been shown to play an important role in tumor metastasis. Here, a method for the isolation and propagation of CTCs from the whole blood of a syngeneic mouse tumor model of hepatocellular carcinoma (HCC) metastasis is described.
03:59
Orthotopic Homograft Tumor Transplantation: A Technique to Generate Pancreatic Tumor Mouse Models
0 Views •
2023
The video explains a stepwise surgical method for orthotopic implantation of a tumor fragment from a cancerous donor to the pancreas of a non-cancerous recipient mice for development of pancreatic cancer. Orthotopically implanted PDAC could recapture the tissue microenvironment of human pancreatic cancers than conventional subcutaneous (SC) models more accurately.
07:12
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
0 Views •
Cited by 29 •
2016
Bioluminescence imaging is a well-known tool for localizing tumors and metastases, but quantification of these images often requires complex calculations and particular instruments. We describe the easy-to-use luminoscore method, based on precise acquisition conditions, requiring no calculations, and enabling tumor burden and treatment response to be monitored in mouse models.
FAQs
The choice of model determines which part of cancer biology an experiment can examine. Transplanted tumor cells or tissue provide a way to evaluate tumor growth and treatment response, whereas cancer-associated genetic changes can address tumor development in a genetically altered setting. Patient-derived tumors add a direct connection to tumors originating from patients, making model selection central to interpretation.
Interactions with the tumor microenvironment help explain why findings in a living mouse may differ from observations made in isolated tumor material. As the tumor grows, it engages blood vessels, immune cells, and surrounding tissue. These relationships can influence progression and treatment response, so investigators can assess not only the tumor itself but also its biological context.
These systems differ in what they preserve and what they are designed to test. Transplantation focuses on introducing tumor cells or tissue, genetic approaches examine consequences of cancer-associated changes, and patient-derived systems retain a direct connection to human tumors. Comparing results across these approaches can separate effects linked to model construction from broader cancer mechanisms.
Controlled experimental conditions make it possible to compare tumor development, progression, and treatment responses across study groups. They also help investigators connect observed effects with candidate therapies, biomarkers, or resistance patterns. Interpretation remains tied to the features represented by the selected model, so each result should be understood in relation to its tumor, genetic, and microenvironmental context.
A typical study begins by selecting a model suited to the scientific question, then establishing the tumor system through transplanted cells or tissue, cancer-associated genetic changes, or a patient-derived tumor. Investigators then follow tumor development or progression and examine responses after treatment exposure. This sequence links model choice, tumor behavior, and therapeutic evaluation within a living organism.
Medicine researchers use these systems to evaluate drug efficacy, toxicity, biomarker identification, and resistance in the context of a living organism. The models can show how treatment responses relate to tumor development, progression, and the surrounding microenvironment. This broader evidence helps connect laboratory observations with potential therapeutic strategies while clarifying how tumors respond to treatment.